01 1Maithri Laboratories Private Limited
01 1Elafibranor
01 1India
NDC Package Code : 71666-024
Start Marketing Date : 2026-03-29
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
53
PharmaCompass offers a list of Elafibranor API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Elafibranor manufacturer or Elafibranor supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Elafibranor manufacturer or Elafibranor supplier.
A Elafibranor manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Elafibranor, including repackagers and relabelers. The FDA regulates Elafibranor manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Elafibranor API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Elafibranor manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Elafibranor supplier is an individual or a company that provides Elafibranor active pharmaceutical ingredient (API) or Elafibranor finished formulations upon request. The Elafibranor suppliers may include Elafibranor API manufacturers, exporters, distributors and traders.
click here to find a list of Elafibranor suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Elafibranor as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Elafibranor API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Elafibranor as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Elafibranor and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Elafibranor NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Elafibranor suppliers with NDC on PharmaCompass.
We have 1 companies offering Elafibranor
Get in contact with the supplier of your choice:
